This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Oxford Finance LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 10 Years Active: 2026
Title: Jacob Gano: Innovator in Targeted Immunotherapies
Introduction
Jacob Gano is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of immunotherapy, particularly with his innovative approach to targeting CD33. His work has the potential to impact the treatment of various diseases, showcasing his dedication to advancing medical science.
Latest Patents
Jacob Gano holds a patent for "CD33 Targeted Immunotherapies." This patent represents a crucial step in the development of targeted treatments that can improve patient outcomes in immunotherapy.
Career Highlights
Gano is currently associated with Oxford Finance LLC, where he continues to work on innovative solutions in the healthcare sector. His experience and expertise have positioned him as a valuable asset in the field of medical research and development.
Collaborations
Throughout his career, Jacob has collaborated with notable professionals, including William S. Crago and Angelica Sanabria. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Jacob Gano's contributions to targeted immunotherapies highlight his role as a key innovator in the medical field. His work not only reflects his expertise but also his commitment to improving healthcare through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile